A Phase II Study of Docetaxel (Taxotere) (NSC 628503, IND 59,761) in Children With Refractory Leukemias
Phase of Trial: Phase II
Latest Information Update: 11 Aug 2011
At a glance
- Drugs Docetaxel (Primary)
- Indications Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 30 Jun 2009 New source identified and integrated (New Jersey Cancer Trial Connect).
- 01 Feb 2007 Status changed from in progress to completed
- 07 Sep 2005 New trial record.